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LETTERS TO THE EDITOR
Regarding ‘Liver cell adenoma and liver cell adenomatosis’ by Ludger
Barthelmes and Iain S. Tait
NIELS F. M. KOK, TU¨RKAN TERKIVATAN & JAN N. M. IJZERMANS
Department of Surgery, Erasmus MC Rotterdam, the Netherlands
Sir,
We read with great interest the recent article by
Barthelmes and Tait (HPB 2005;7:186/196).
The impact of the diagnosis ‘liver cell adenoma’ on
the life of a young female patient is enormous.
Conservative management of liver cell adenoma
frequently implies cessation of oral contraceptives,
regular follow-up including radiological imaging,
and negative advice regarding pregnancy. Surgical
treatment of solitary adenomas implies the risk of
morbidity and mortality following hepatic resection
and does not guarantee relief of complaints. However,
the risk of bleeding from or malignant transformation
of that solitary adenoma is prevented. The debate
whether to manage solitary adenomas conservatively
or surgically continues. A recent retrospective study
by Toso et al. [1] recommended resection of solitary
adenomas. The review by Barthelmes and Tait
summarized most of the insight in the diagnosis and
management of liver cell adenomas during the past
decades. Based on their review, they strongly
recommended surgical resection for hepatocellular
adenomas.
The investigators reviewed 14 adenoma series that
included 167 patients in total and covered the era
between 1979 and 2002. The authors addressed the
diagnostic difficulties, in particular the differentiation
of liver cell adenomas from well-differentiated hepa-
tocellular carcinoma. Furthermore, they discussed the
risk of bleeding and malignant transformation.
Although we agree with the authors that hepatic
lesions with an uncertain diagnosis or adenomas at
risk for bleeding or malignant transformation should
be treated surgically, we think conservative treatment
including careful follow-up is applicable to some
patients.
Our current management of liver cell adenoma
is based on the study by Terkivatan et al. [2], which
included 33 patients, of whom 19 were treated
surgically and 14 were treated conservatively.
The guideline to excise liver cell adenomas if larger
than 5 cm, referenced by Barthelmes and Tait,
originated from that study. With this guideline,
we saved several women from hepatic resection. In
the past 5 years, we discussed all patients with benign
liver tumours in a weekly multidisciplinary meeting
with a hepatologist, a radiologist specialized in the
liver and a pathologist. Conservative management was
chosen in case of a certain benign radiological
diagnosis and a lesion smaller than 5 cm. In case of
absent regression, adenomas were resected at a later
stage. After withdrawal from oral contraceptives,
bleeds did not occur.
We believe that this management is justified due
to the rapid evolution of magnetic resonance imaging
(MRI) of benign liver tumours. Further prospective
studies that include modern MRI approaches
should determine whether lesions with a certain
radiological diagnosis of liver cell adenoma can also
progress to a carcinoma or that the reported cases of
malignant degeneration in the past originated
from lesions which could not possibly be character-
ized as either liver cell adenoma or hepatocellular
carcinoma. Modern molecular techniques can
possibly be helpful in distinguishing the two different
entities [3].
Furthermore, it is not well documented whether
bleeds occur after cessation of oral contraceptives.
The main problem of most of the cited studies is the
retrospective design. Prospective studies addressing
accepted 22 December 2005
ISSN 1365-182X print/ISSN 1477-2574 online # 2006 Taylor & Francis
DOI: 10.1080/13651820500537879
Correspondence: Professor Jan N. M. Ijzermans, Department of Surgery, Room H10-49, Erasmus MC Rotterdam, Dr. Molewaterplein 40, 3015 GD
Rotterdam, The Netherlands. Tel: /31 10 4632848. E-mail: j.ijzermans@erasmusmc.nl
HPB, 2006; 8: 71/74
the superiority of surgical management over conser-
vative management in patients with a clear diagnosis
of solitary liver cell adenoma have to be conducted
before conservative treatment can be abandoned.
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Ascariasis-induced eosinophilic cholecystitis / a unique case
OMAR J. SHAH & PARVEEN SHAH
Department of General Surgery, Sher-I-Kashmir Institue of Medical Sciences, Srinagar, Kashmir, India
Sir,
I would like to bring to the attention of your readers
the following unique case of ascariasis-induced
eosinophilic cholecystitis. The condition was first
described in 1949 and is characterized by dense,
transmural infiltration of the gall bladder wall with
eosinophils [1]. This rare condition has received
attention from French workers [2] who consider it
to be a discrete clinical and pathological entity due to
a local allergic process within the gall bladder. On
occasion, a large number of eosinophil leukocytes are
seen in the wall of surgically removed gall bladders. It
is recognized that eosinophils may appear in and often
from a substantial component of the pleomorphic
cellular infiltrate which is found in gall bladders
removed 2/3 weeks after an episode of acute chole-
cystitis, but the significance of an almost pure
eosinophilia of the gall bladder is usually not clear
either to the histopathologist or the surgeon. Eosino-
philic infiltration of the biliary tract may be idiopathic
or may represent a variant of eosinophilic gastroenter-
itis or may be associated with parasitic infestation.
Histopathologically there should be little problem in
differentiating eosinophilic cholecystitis from the
more usually encountered varieties, clinically there
seems to be no difference. The presence of eosino-
philia in certain parasitic infections, particularly those
helminthic infections that invade tissue, has been
recognized particularly from the time the eosinophil
was discovered. Yet its role in parasitic disease is
still disputed. Although eosinophils are capable of
phagocytosing bacteria and other microorganisms,
their efficacy in this regard is felt to be inferior to
the neutrophil.
A 40-year-old female presented to our hospital with
signs and symptoms of acute cholecystitis. Abdominal
ultrasonography revealed a distended thick-walled gall
bladder with a long coiled tubular echogenic structure
within it. A diagnosis of gall bladder ascariasis with
acute cholecystitis was made. The patient was man-
aged conservatively but did not show any improve-
ment even after 1 week’s treatment. Cholecystectomy
was carried out and on histopathological examination
of the specimen a pure transmural infiltration of
numerous eosinophils in the gall bladder tissue was
seen and a final diagnosis of eosinophilic cholecystitis
was made. This is the first reported case of eosino-
philic cholecystitis induced by gall bladder ascariasis.
The parasite may have induced a hypersensitivity
reaction with numerous eosinophils in the gall bladder
wall. In a recent report of eosinophilic cholecystitis
associated with hepatic hydatid cyst ruptured into
biliary tract, the cause of eosinophilic cholecystitis was
similarly attributed to the hypersensitivity reaction
[3]. We would agree with the French workers [2]
who consider this to be a local allergic process that
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